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ABSTRACT 
Objective: Reference intervals (RIs) currently being used in Ethiopia are derived from western 
populations. Thus, this study aimed to establish locally derived hematological and immunological 
RIs.  
Method: The study was conducted in Amhara State, Ethiopia with a total of 967 (55.2% males) 
participants. 56.9% of males and 43.1% of females were eligible for hematological and 
immunological RI determination. A non-parametric test was used for the determination of upper 
(97.5th percentile) and lower (2.5th percentile) reference interval limits with 95% CI. The Harris and 
Boyd Rule was used to determine the need of partitioning of reference intervals based on sex.  
Result: The established 95% reference intervals (2.5th – 97.5th percentile) were: for WBC: 3 – 11.2 
x109/L; for platelet: 90 – 399 x109/L; for RBC: 4 – 6 x1012/L for males and 3.5 – 5.6 x1012/L for 
females; for hemoglobin: (Hgb) 12 – 18.9g/dl for males and 10.7 – 17.5g/dl for females; for PCV: 35.7 
– 55.3% for males and 32.2 – 50.1% for females; for CD4: 400 - 1430 x109/L for males and 466 - 1523 
x109/L for females; for CD4 percentage: 18 – 49.1% for males and 21.3 – 52.9% for females; for MCV: 
81 – 100fl; for MCH: 25.3 – 34.6pg; MCHC: 28.8 – 36.9%; for RDW: 11.6 – 15.4% and for MPV: 8 – 
12.3fl. Males had significantly higher RBC, Hgb and PCV than females. CD4 counts and CD4 
percentage were significantly higher in females.  
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Conclusion: The reference intervals established in this study differ from others and thus should be 
used for the interpretation of laboratory results in diagnosis and safety monitoring in clinical trials in 
Amhara. 
 
Keywords: Reference interval, Hematological parameter, Immunological parameter, Amhara 
 
INTRODUCTION  
Reference intervals (RIs) are also popularly known as reference ranges, normal values, normal 
ranges, biological reference intervals, and expected values (1). In clinical practice, before 
physiological assessments, medical diagnosis and management decisions are made, patient's 
laboratory results are compared with the corresponding reference intervals (RIs), which are bounded 
by a pair of reference limits (1, 2). RIs aid physicians in decision-making in clinical medicine to 
interpret results, in evaluating the state of health of individuals and populations, in identifying 
people at risk for disease, in assessing immune status, disease progression and treatment responses 
(3). They may also be used in clinical trials as a guide to setting inclusion or exclusion criteria and 
form the basis for safety monitoring of trial participants (4). 
 Laboratory parameters vary considerably between healthy people from different geographical 
locations, mostly driven by ethnic, genetic, demographic, nutritional, economic and environmental 
differences (5-10). Moreover, they vary from laboratory to laboratory due to differences among 
laboratories in clinical service needs, analytic platforms, set criteria to define populations of healthy 
individuals, analytic imprecisions made when RIs were determined, differences in methods used to 
establish RIs, techniques and timing of blood collection, subject’s posture when the sample is taken, 
and physical activity of individuals (11-13).  
 Despite these differences, most African countries including Ethiopia use western population-
derived laboratory RIs for clinical diagnosis and research activities. Studies conducted to evaluate 
and establish locally derived RIs in several African countries (6, 7, 14-22) revealed significant 
differences of locally derived RIs from those of currently used western population-derived RIs. This 
may lead to misclassification of patients that may result in misdiagnoses, improper treatments or 
both. Unless RIs are representative of the patient’s demographics and determined using similar pre-
analytical procedures and comparable analytical methods, they are inappropriate as a diagnostic 
reference for clinical decision-making.  
 Several factors affect hematological and immunological parameters. Therefore the Clinical 
Laboratory Standards Institute/International Federation for Clinical Chemistry (CLSI/IFCC) 
recommends that each laboratory establish RIs from the local population (5, 10, 12). Although some 
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attempts have been made to determine RIs in Ethiopia, they are fragmented and specific to small 
groups (14, 15), not comprehensive enough to be used in clinical practice (16, 22-24) and may lead 
to wrong interpretation (25). The RIs currently being used in Ethiopia are derived from Caucasian 
populations.  
 Therefore, we aimed to establish locally derived RIs of hematological and immunological 
parameters for adults in the state of Amhara, Ethiopia. This the first study in the country covering a 
large population.  
 
METHODS 
Study setting and design 
This was a cross-sectional study of 1,040 blood donors in the Amhara blood bank districts of Gondar, 
Bahirdar, Debre Markos and Dessie to determine hematological and immunological RIs. Amhara (9° 
to 13° 45' N and 36° to 40° 30'E;  500 – 4,620 m asl, 159,173.66 km2) comprises hot dry tropical, sub-
tropical, temperate and alpine climatic zones. In 2007 Amhara had a population of 17.2 million; 
51.9% of the Ethiopian population were aged 15 – 64 years and and 45% were children <15 years 
(26).  
 
Selection of reference population 
We used a convenience sampling technique to select the reference population during blood 
donation. Each blood bank has a fixed blood collection center and mobile blood collection sites. The 
mobile blood collection teams campaign in the community and collect blood from volunteers. The 
objective of the study was explained to the donors and informed consent taken. Volunteers’ general 
good health was assessed through a medical history and physical examination. Donors were 
screened for infectious diseases by the Ethiopian blood bank service after blood donation. We 
excluded individuals known to have diabetes mellitus, chronic renal insufficiency, hypertension, 
ischemic heart disease, anemia, thyroid or liver disease; those taking pharmacologically active 
substances or any prescription drugs; smokers; individuals who had malaria in the previous 3 
months, individuals who had jaundice or major surgery in the past year; pregnant (determined 
clinically or by urine HCG test) and lactating women; individuals who had donated blood in the 
previous 4 months and those who had received a blood transfusion in the previous year. Serum 
blood samples were screened for HIV, Hepatitis B virus, Hepatitis C virus and syphilis using ELISA 
techniques at each blood bank center. 
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Laboratory analysis 
Four ml of blood were collected from the antecubital vein into a K3EDTA vacutainer tube for CD4 
and complete blood count. A three-part differential complete blood count (CBC) was analyzed using 
CELL-DYN® 1800 (Abbott Laboratories Diagnostic Division, USA) at each blood bank center. We used 
diluent, detergent and CN-free diff lyse CELL-DYN reagents supplied by Abbott Laboratories 
Diagnostic Division. The analyzer used electrical impedance to count and size blood cells and the 
methemoglobin method for determination of Hgb, based on the measurement of changes in 
electrical resistance produced by cells suspended in conductive diluents as they pass through an 
aperture of known dimensions. As each cell passes through the aperture, a transitory change in the 
resistance between the electrodes occurs, producing a measurable electrical pulse. The number of 
pulses generated indicates the number of cells and the amplitude of each pulse is proportional to 
cell volume. In this manner cells are counted and classified into white blood cells (WBC), red blood 
cells (RBC) and platelets. Hemoglobin (Hgb), packed cell volume (PCV), absolute and relative number 
of lymphocytes, neutrophils and mixed cells (basophils, monocytes, eosinophils), mean cell volume 
(MCV), mean cell hemoglobin (MCH) and mean cell hemoglobin concentration (MCHC) were 
analyzed.  
 CD4 cell counts and CD4 percentages were determined using a Becton Dickinson Fluorescence 
Activated Cell Sorting (BD FACS) Count™ system (Becton Dickinson, San Jose, CA, USA), which 
provides reproducible and accurate results even with low CD4 counts and is widely used for CD4 
monitoring in HIV/AIDS treatment programs. BD FACS Count reagents are provided as complete kits 
that streamline CD4 counting. These kits contain ready-to-use tubes with pre-measured antibodies 
and beads for absolute counting, fixative solution, and software that enables automated analysis 
without operator intervention. The beads and lymphocytes of interest are automatically identified 
and absolute counts (cells/μL) and percentages calculated. Quality controls in the software detect 
and flag error conditions and suppress results when control limits are exceeded. 
 
Quality Control 
Protocols for sample collection, processing and transportation were strictly followed to have safe 
procedures and reliable specimens. Samples were analyzed in batches within two hours of collection 
and delayed samples were kept at 2 – 8OC for a maximum of 12 hours. During analysis, both internal 
and external quality assurance (QA) protocols were followed. As an internal QA, commercial quality 
control samples were included in every batch. Test samples were run if and only if quality control 
samples were within range. For hematology tests three levels of whole blood controls (High, 
Medium, and Low) and for CD4 cell count, two levels of whole blood controls (Low, Normal) were 
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used. All analytes were analyzed by following standard operational procedures. As an external QA, 
the laboratory received quality control samples from the central laboratory, analyzed them as a 
patient sample and returned them to the center. The central laboratory then analyzed the data and 
gave performance evaluation feedback to each laboratory. The central laboratory received QA 
materials from UK and Canada.  
 
Statistical Analysis 
Data were checked for completeness, cleaned, edited and entered into Epi-Info version 3.5.1 and 
then transported to SPSS v. 20 for statistical analysis. Outliers within each subgroup were identified 
using the Dixon and Reed method, namely the D/R ratio, where D is the absolute difference between 
an extreme observation (large or small) and the next largest (or smallest) observation, and R is the 
range (maximum – minimum). Extreme values were deleted from the distribution if D/R ≥1/3 (5). RIs 
were calculated according to the guideline of the Clinical Laboratory Standards 
Institute/International Federation for Clinical Chemistry (CLSI/IFCC) by employing a nonparametric 
method to determine the median interquartile ranges (IQR), combined or separate 95% RIs (2.5th 
and 97.5th percentiles). The 2.5th and 97.5th percentiles were considered as lower and upper 
reference limits, respectively, covering 95% of the reference interval of each parameter (5). RIs were 
determined separately for males, females and combined sexes. To determine combined or separate 
sex RIs, the Harris and Boyd test was used as described below (27, 28):  
  
             
                   
 
where SD is standard deviation and N is the number of samples of each sex. This statistical Z result 
was compared with a critical Z* value: 
                     
Separate RI was determined when Z > Z*. Based on this test, separate-sex RIs were determined for 
RBC, Hgb, PCV, CD4 and CD4 percentages (Table 1).  
 
Ethics  
This study was approved by the Research Review Board of University of Gondar and permission was 
obtained from the blood banks. Written informed consent was obtained from each participant. The 
study participants were informed about the aim of the study and its procedure, and inclusion was 
voluntary. Confidentiality was kept and withdrawal was possible at any stage.  
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RESULTS 
We enrolled 1,040 volunteer blood donors aged 18-61 years. 55.4% were male and 44.6% female. Of 
the total, 967 (55.2% males and 44.8% females) were eligible for hematological RI determination and 
784 (56.9% males and 43.1% females) were eligible for immunological RI determination. The median 
age of study participants was 20 years with an IQR of 5 years. 80% were students aged 18-25 years.  
 The median and 95% reference intervals (2.5th – 97.5th percentiles) for hematological and 
immunological parameters are shown in Table 2. The combined median and 95th percentile for both 
sexes were as follows:  6.1 (3 – 11.2 x109/L) for WBC, 3.2 (1.1 – 6.7 x109/L) for absolute neutrophils, 
2.1 (1.1 – 4.5 x109/L) for absolute lymphocytes, 0.7 (0.2 – 2.1 x109/L) for absolute mixed cells, 239 
(90 – 399 x109/L) for platelet, 90.1 (81 – 100fl) for MCV, 30 (25.3 – 34.6pg) for MCH, 33.9 (28.8 – 
36.9%) for MCHC, 13.2 (11.6 – 15.4%) for RDW and and 10 (8 – 12.3fl) for MPV for both sexes.  
 The separate RIs for males were: 5.1 (4 – 6 x1012/L) for RBC, 15.3 (12 – 18.9g/dl) for Hgb, 46.2 
(35.7 – 55.3%) for PCV, 721 (400 - 1430 x109/L) for CD4 and 36.3 (18 – 49.1%) for CD4 percentage. 
RIs for females were 4.5 (3.5 – 5.6 x1012/L) for RBC, 13.1 (10.7 – 17.5g/dl) for Hgb, 39.9 (32.2 – 
50.1%) for PCV, 830 (466 - 1523 x109/L) for CD4 and 40.3 (21.3 – 52.9%) for CD4 percentage. Males 
had significantly higher RBC, Hgb and PCV than females, whereas CD4 counts and CD4 percentages 
were significantly higher in females. The distribution of these variations with sex are expressed in 
Box and Whisker plots (Figure 1). 
 
DISCUSSION 
Local RIs are recommended to be established and used for interpretation of laboratory results 
during screening, diagnosis and monitoring of patients and to assure the health status of individuals 
involved in clinical trials (4-6, 12). The RIs derived in this study varied from those reported in other 
areas (6, 14, 15, 29-31) and in text books (12, 32-34), as would be expected for populations in other 
geographical locations, with genetic and dietary diversities (5). As indicated in Table 3, the lower RI 
limit of total WBC count in this study was lower than previously reported from different parts of 
Ethiopia (14, 15), Eastern and Southern Africa (6), Western Kenya (7), Ghana (29), USA (30) and 
Caucasian populations (12, 32, 33); but it was higher than in Kericho district of Kenya (31), Togo (35) 
and Uganda (4). The WBC RI for this study is in agreement with southern Tanzania’s (36) RI lower 
limit, whereas our upper RI limit was lower than in Gojjam district of Ethiopia (15), in books (32, 33) 
but higher than reported from Africa (4, 6, 7, 14, 31, 35), USA (30) and in text books (12, 34). 
Similarly the absolute neutrophil and lymphocyte count RI upper limits are higher than in most 
African countries RIs (4, 6, 7, 14, 31, 35) but lower than in Caucasian populations (12, 30, 34). These 
variations are usually associated with well-known differences in altitude, environment, diet, and 
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ethnic background (5). There was no significant difference in WBC count between males and 
females, confirming results of other studies (6, 14, 15, 29-31).  
 The 95th percentile RIs of our lower limit RI of RBC in both sexes were lower than those in Kenya 
(7, 31), Tanzania (36), USA (30) and western text books (32, 34) and higher than in previous studies 
in Gondar, Ethiopia (14), Ghana (29), Togo (35) and Uganda (4). The upper limit RI was lower than 
previous studies in Ethiopia (14, 15), Togo (35) but higher than in Ghana (29), USA (30) and in 
western books (32, 34). The differences might be due to geographical variation (altitude), 
environment, diet, ethnic background, method and instrument used for analysis (CLSI) (5, 17).  
 The lower limit of Hgb and PCV RIs in this study was lower than in Gojjam (15), Tanzania (36) 
and the USA (30),  but higher than in Eastern and Western Africa (6), Ghana (29), Western Kenya (7), 
Togo (35) and Uganda (4) for both sexes. The upper limit of Hgb was higher than in Eastern and 
Western Africa (6), Ghana (29), Kenya (7, 31), Togo (35), Uganda (4), USA (30) but lower than in 
Gojjam (15), probably due to altitude and ethnic variations (5, 37, 38). Thus it may not be possible to 
even have one standard reference between two localities in the same county, as seen in Ethiopia 
and Kenya (7, 14, 15, 31).  
 The reference intervals of MCV, MCH and MCHC in this study varied from those of other studies 
(Table 3). Generally the RI of MCV is higher than in other African countries (4, 6, 7, 29, 31, 36) and 
comparable with Togo (35), USA (30) and values in text books (34).  MCH and MCHC values showed 
variable results and RDW RIs are comparable with other studies (30, 34).  
 We observed a significant sex difference on red cell parameters (RBC, Hgb and PCV). Higher 
values were seen in males than females, confirming previous findings (12, 32-34) in Ethiopia (14, 15), 
Eastern and South Africa (6), Ghana (29), Kenya (7, 31), South Tanzania (36), Togo (35), Uganda (4) 
and USA (30). The significant differences between men and women in RBC, Hgb and PCV may be due 
to biological and physiological factors such as the influence of androgen hormone on erythropoiesis 
(39) and menstrual blood loss in females (40).  
 The RIs of platelets in this study were lower than in Gondar (14), Eastern and Southern Africa 
(6), Kenya (7, 31), Togo (35) and Caucasian populations  (32, 34). However, the RI values are higher 
than Ghana (29). This is may be associated with high altitude in Ethiopia, as platelet count decreases 
and mean platelet volume (MPV) increases with altitude (41-43). 
 CD4 RI determination is also important because CD4 lymphocyte cells are used for assessment 
of immune status, disease progression and treatment responses of patients, especially individuals 
living with HIV (3, 44).  CD4 cell counts were higher than in Addis Ababa (16), Tanzania (21) and 
Central African Republic (20); but lower than in Gojjam, Ethiopia (15), Gauteng, South Africa (45) and 
Turkey (46). CD4 percentages RI in this study were generally lower than in other countries (7, 16, 45, 
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46), possibly due to ethnic and environmental factors (47, 48). There was a significant sex difference 
in absolute CD4 cells and CD4 percentages. The higher values seen in women in our study are 
consistent with other studies (7, 15, 16, 19, 20, 45) and may be due to the effect of sex hormones 
(49).  
 One limitation of our study is that the majority of the reference population included were young 
adults. Secondly, we did not screen the reference population for infectious diseases such as 
intestinal parasites.  
 
CONCLUSION 
The reference values we established for the state of Amhara, Ethiopia will be helpful for the 
screening, diagnosis, monitoring and follow-up of patients. This study provides the first 
hematological and immunological RIs for a larger population in the state of Amhara, Ethiopia, and is 
the largest in the country. The RIs generated in Amhara differ from others in Africa and western 
countries. The WBC RI showed a wider range, with lower and upper RI limits showing variations from 
previous studies. Similarly, RBC parameters (RBC, Hgb and PCV), showed a slightly higher upper RI 
limit, whereas platelet counts, absolute CD4 counts and CD4 percentages gave lower RIs in this 
study. Thus the use of western RIs could lead to wrong diagnosis and interpretation of laboratory 
results. It is also advisable to establish RIs for the younger and older populations, giving due 
consideration to the effect of infectious diseases on hematological and immunological parameters.   
 
Acknowledgements 
The authors would like to thank the study participants for volunteering to participate in this study; 
the staff of the Gondar, Bahirdar, Debre Markos and Dessie Blood Banks for their support during 
data collection and infectious disease screening; the University of Gondar hospital, Amhara Public 
Health Institute Laboratory, Debre Markos Hospital and Dessie Referral Hospital Laboratory staff 
who supported for hematological and CD4 laboratory analysis; and the University of Gondar for 
funding the project. The datasets during and/or analyzed during the current study available from the 
corresponding author upon request. 
 
 
 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
REFERENCES 
1. Solberg HE. Establishment and use of reference values. In: Burtis CA, Ashwood ER, Bruns DE, 
editors. Tietz fundamentals of clinical chemistry. 6th ed. Philadelphia: Saunders; 2008. p. 232. 
2. Friedberg RC, Souers R, Wagar EA, Stankovic AK, Valenstein PN, Pathologists CoA. The origin of 
reference intervals. Archives of pathology & laboratory medicine. 2007;131(3):348-57. Epub 
2007/05/23. 
3. Embree J, Bwayo J, Nagelkerke N, Njenga S NP, Ndinya-Achola J, Pamba H, et al. Lymphocyte 
subsets in human immunodeficiency virus type 1-infected and uninfected children in Nairobi. 
Pediatr Infect Dis J. 2001;20(4):397-403. 
4. Eller LA, Eller MA, Ouma B, Kataaha P, Kyabaggu D, Richard Tumusiime, et al. Reference 
intervals in healthy adult Ugandan blood donors and their impact on conducting international 
vaccine trials. PLoS ONE. 2008;3(12):e3919. 
5. CLSI. Defining, Establishing, and Verifing Reference Intervals in the Clinical Laboratory; Approved 
Guideline-Third Edition. CLSI document EP28-A3c. Wayne, PA: Clinical and Laboratory Standards 
Institute; 2008. 
6. Karita E, Ketter N, Price MA, Kayitenkore K, Kaleebu P, Nanvubya A, et al. CLSI-derived 
hematology and biochemistry reference intervals for healthy adults in eastern and southern 
Africa. PloS one. 2009;4(2):e4401. 
7. Zeh C, Amornkul PN, Inzaule S, Ondoa P, Oyaro B, Mwaengo DM, et al. Population-based 
biochemistry, immunologic and hematological reference values for adolescents and young 
adults in a rural population in Western Kenya. PloS one. 2011;6(6):e21040. 
8. Paul S. Horn, Amadeo J. Pesce. Effect of Ethnicity on Reference Intervals. Clin Chem. 
2002;489(10):1802-4. 
9. Siqués P, Brito J, León-Velarde F, Barrios L, De La Cruz JJ, López V, et al. Hematological and Lipid 
Profile Changes in Sea-Level Natives after Exposure to 3550-m Altitude for 8 Months. High 
altitude medicine & biology. 2007 8(4):286 -95. 
10. PetitClerc C, Solberg HE. Approved recommendation on the theory of reference values (1987). 
Part 2. Selection of individuais for the production of reference values. J Clin Chem Clin Biochem. 
1987;25(9):639-44. 
11. Howanitz PJ, GS. C. Postanalytical quality improvement: a College of American Pathologists Q-
Probes study of elevated calcium results in 525 institutions. Arch Pathol Lab Med 2000;124:504-
10. 
12. Bates I, Lewis SM. Reference ranges and normal values. In: Bain BJ, Bates I, Laffan MA, Lewis SM, 
editors. Dacie and Lewis Practical Haematology. 11th ed. London: Churchil Livingstone: Elsevier; 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
2011. p. 14. 
13. Arneson W, Brickell J, Crellin M, Cavagnaro M. Clinical chemistry a laboratory perspective: 
Quality Assessment. Philadelphia, PA, USA.: F. A. Davis Company; 2007. 
14. Yalew A, Terefe B, Alem M, Enawgaw B. Hematological reference intervals determination in 
adults at Gondar university hospital, Northwest Ethiopia. BMC research notes. 2016;9(1):483. 
Epub 2016/11/04. 
15. Mulu W, Abera B, Mekonnen Z, Adem Y, Yimer M, Zenebe Y, et al. Haematological and CD4+ T 
cells reference ranges in healthy adult populations in Gojjam zones in Amhara region, Ethiopia. 
PLoS One. 2017;12(7):e0181268. Epub 2017/07/21. 
16. Tsegaye A, Messele T, Tilahun T, Hailu E, Sahlu T, Doorly R, et al. Immunohematological 
reference ranges for adult Ethiopians. Clin Diagn Lab Immunol. 1999;6(3):410–114. 
17. Aneke C Nduka N, Maxwell-Owhochuku S. Comparison of some haematological indices of 
Africans and Caucasions resident in the Nigerian environment. Haematologia (Budapest). 
1988;21(1):57-63. 
18. Klose N, Coulibaly B, Tebit D, Nauwelaers F, Spengler H, Kynast-Wolf G, et al. 
Immunohematological reference values for healthy adults in Burkina Faso. Clinical and Vaccine 
Immunology. 2007;14(6):782-4. 
19. Lugada Es, Mermin J, Kaharuza F, Ulvestad E, Were W, Langeland N, et al. Population-based 
hematologic and immunologic reference values for a healthy Ugandan population. Clinical and 
Diagnostic Laboratory Immunology. 2004;11(1):29-34. 
20. Menard D, Mandeng MJ, Tothy MB, Kelembho EK, Gresenguet G, Talarmin A. 
Immunohematological reference ranges for adults from the Central African Republic. Clin Diagn 
Lab Immunol. 2003;10(3):443-5. 
21. Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O. Immunohaematological reference values in human 
immunodeficiency virus-negative adolescent and adults in rural northern Tanzania. BMC 
Infectious Diseases. 2009;9:1. 
22. Gelaye B, Bekele T, Khali A, Haddis Y, Lemma S, Berhane Y, et al. Laboratory reference values of 
complete blood count for apparently healthy adults in Ethiopia. Clinical laboratory. 2011;57(7-
8):635-40. Epub 2011/09/06. 
23. Gize A, Mathewos B, Moges B, Workineh M, Gedefaw L. Establishment of Normal Reference 
Intervals for CD3(+), CD4(+), CD8(+), and CD4(+) to CD8(+) Ratio of T Lymphocytes in HIV 
Negative Adults from University of Gondar Hospital, North West Ethiopia. AIDS research and 
treatment. 2014;2014:267450. Epub 2014/12/09. 
24. Kassu A, Tsegaye A, Petros B, Wolday D, Hailu E, Tilahun T, et al. Distribution of lymphocyte 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two 
geographic locales. Clin Diagn Lab Immunol. 2001;8(6):1171-6. Epub 2001/11/01. 
25. Haileamlak A, Muluneh AT, Alemseged F, Tessema F, Woldemichael K, Asefa M, et al. 
Hematoimmunological profile at gilgel gibe field research center, southwest ethiopia. Ethiopian 
journal of health sciences. 2012;22(S):39-50. Epub 2013/01/16. 
26. Federal Democratic Repobulic of Ethiopia Population Census Commission. Summary and 
statistical report of the 2007 population and housing census. Population size by age and sex. 
2008. Available at: https://www.scribd.com/doc/28289334/Summary-and-Statistical-Report-of-
the-2007; Acess on September 1, 2017. 
27. Harris EK, Boyd JC. On dividing reference data into subgroups to produce separate reference 
ranges. CLIN CHEM. 1990;36(2):265-70. 
28. Harris EK, Wong ET, Shaw ST. StatisticalCriteriafor Separate Reference Intervals:Race and 
Gender Groupsin Creatine Kinase. Clin Chem. 1991;37(9):1580-2. 
29. Dosoo DK, Kayan K, Adu-Gyasi D, Kwara E, Ocran J, Osei- K, et al. Haematological and 
Biochemical Reference Values for Healthy Adults in the Middle Belt of Ghana. PLoS ONE. 
2012;7(4):e36308. 
30. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Case records of the massachusetts general 
hospital: Laboratory Reference Values. The New England journal of medicine. 2004;351:1548-
63. 
31. Kibaya RS, Bautista CT, Sawe FK, Shaffer DN, Sateren WB, Scott PT, et al. Reference Ranges for 
the Clinical Laboratory Derived from a Rural Population in Kericho, Kenya. PLoS ONE. 
2008;3(10):e3327. 
32. Turgeon ML. Clinical Hematology Theory and Procedures. 5 ed. Philadelphia, PA: Lippincott 
Williams & Wilkins; 2012. 
33. Rodak BF, Fritsma GA, Keohane EM. Hematology: Clinical principles and applications. 4 ed. St. 
Louis, Missouri: Elsevier Saunders; 2011. 
34. Keohane EM, Smith LJ, Walenga JM. Rodak’s Hematology: Clinical principles and applications. 4 
ed. St. Louis, Missouri: Elsevier Saunders; 2016. 
35. Kueviakoe IM, Segbena AY, Jouault H, Vovor A, Imbert M. Hematological reference values for 
healthy adults in Togo. ISRN Hematology. 2011;2011. 
36. Saathoff E, Schneider P, Kleinfeldt V, Geis S, Haule D, Maboko L, et al. Laboratory reference 
values for healthy adults from southern Tanzania. Tropical Medicine and International Health. 
2008;13(5):612–25. 
37. Kaya H, Kiki I, Akarsu E, Gundogdu M, Basol Tekin S, Inandi T. Hematological Values of Healthy 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Adult Population Living at Moderate Altitude (1869 m, Erzurum, Turkey). Turkish journal of 
haematology : official journal of Turkish Society of Haematology. 2000;17(3):123-8. Epub 
2000/09/05. 
38. Al-Sweedan SA, Alhaj M. The effect of low altitude on blood count parameters. 
Hematology/oncology and stem cell therapy. 2012;5(3):158-61. Epub 2012/10/26. 
39. Bachman E, Travison TG, Basaria S, Davda MN, Guo W, Li M, et al. Testosterone induces 
erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new 
erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci. 2014;69(6):725-35. 
40. Kim I, Yetley EA, Calvo MS. Variations in iron-status measures during the menstrual cycle. Am J 
Clin Nutr. 1993;58:705-9. 
41. Vij AG. Effect of prolonged stay at high altitude on platelet aggregation and fibrinogen levels. 
Platelets. 2009;20(6):421-7. Epub 2009/08/07. 
42. Hartmann S, Krafft A, Huch R, Breymann C. Effect of altitude on thrombopoietin and the platelet 
count in healthy volunteers. Thrombosis and haemostasis. 2005;93(1):115-7. Epub 2005/01/05. 
43. Hudson JG, Bowen AL, Navia P, Rios-Dalenz J, Pollard AJ, Williams D, et al. The effect of high 
altitude on platelet counts, thrombopoietin and erythropoietin levels in young Bolivian airmen 
visiting the Andes. International journal of biometeorology. 1999;43(2):85-90. Epub 1999/11/07. 
44. O'Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, et al. Changes in plasma HIV-1 
RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs 
Cooperative Study Group on AIDS. The New England journal of medicine. 1996;334(7):426-31. 
Epub 1996/02/15. 
45. Lawrie D, Coetzee LM, Becker P, Mahlangu J, Stevens W, Glencross DK. Local reference ranges 
for full blood count and CD4 lymphocyte count testing. S Afr Med J. 2009;99:243-8. 
46. Yaman A, Çetiner S, Kibar F, Tasova Y, Seydaoglu G, Dündar IH. Reference Ranges of Lymphocyte 
Subsets of Healthy Adults in Turkey. Med Princ Pract. 2005;14:189–93. 
47. Moreno-Galvan M, Palafox A. CD4+ CD8+ T cell reference values in the Mexico City population. 
Clinical and vaccine immunology : CVI. 2013;20(2):306-8. Epub 2012/12/15. 
48. Choong ML, Ton SH, Cheong SK. Influence of race, age and sex on the lymphocyte subsets in 
peripheral blood of healthy Malaysian adults. Annals of clinical biochemistry. 1995;32 ( Pt 
6):532-9. Epub 1995/11/01. 
49. Pernis AB. Estrogen and CD4+ T cells. Current opinion in rheumatology. 2007;19(5):414-20. Epub 
2007/09/01. 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
Correspondence: Bamlaku Enawgaw, Department of Hematology & Immunohematology, School of 
Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, 
Gondar, Ethiopia. Email: bamlak21@gmail.com  
 
Figure legend 
 
Figure 1. Box and whisker plots indicating the effect of sex on hematological and immunological 
parameters of the study participants. a: Red blood cells, b: Hemoglobin, c: Packed Cell Volume, d: 
CD4 Counts and e: CD4 % 
 
Table 1: Result of Harris and Boyd test, which was performed to see the need for partitioning of 
Reference interval based on sex 
 
Parameters  Harris and Boyd Decision  
Z* Z 
WBC (×109/L)  6.0 0.7 No separate RI 
Neutrophil (×109/L) 6.0 1.1 No separate RI 
Lymphocyte (×109/L) 6.0 0.1 No separate RI 
Mixed cells (×109/L) 6.0 0.6 No separate RI 
Neutrophil (%)  6.0 1.2 No separate RI 
Lymphocyte (%)  6.0 0.3 No separate RI 
Mixed cells % 6.0 2.0 No separate RI 
Platelet (×109/l)  6.0 3.3 No separate RI 
RBC (×1012/L) ** 6.0 18.6 Separate RI 
Hgb (g/dl)**  6.0 16.7 Separate RI 
PCV (%) **  6.0 19 Separate RI 
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MCH (pg)  6.0 1.3 No separate RI 
MCHC (g/dl)  6.0 0.6 No separate RI 
MCV (fl)  6.0 1.7 No separate RI 
RDWCV 6.0 3.4 No separate RI 
MPV 6.0 1 No separate RI 
CD4 (×109/L) ** 5.4 6.2 Separate RI 
CD4 percentage** 5.4 6.7 Separate RI 
 
Z* = critical value, Z = calculated value, Separate RI are needed only when Z is greater than Z*; ** 
indicate hematological and CD4 parameters which need partition between male and female (Z > Z*) 
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Table 2: Median, IQR, and 95th percentile of reference interval with lower and upper limit 95% CI of 
hematological and immunological parameters  
Parameter  N Median (IQR) 
RI (95th 
percentile) 
Lower Limit 95% 
CI  
Upper Limit  
95% CI 
WBC (×109/L) 967 6.1 (4.8 – 7.7) 
 
3 – 11.2  3 (2.7 – 3.1) 11.2 (10.8 – 11.9) 
Neutrophil (×109/L) 967 3.2 (2.2 - 4.2) 
 
1.1 – 6.7 1.1 (0.9 - 1.2) 6.7 (6.5 - 6.9 
Lymphocyte (×109/L) 967 2.1 (1.7 – 2.6) 
 
1.1 – 4.5 1.1 (1 - 1.2) 4.5 (4.2 - 4.7) 
Mixed cells (×109/L) 967 0.7 (0.5 - 1) 
 
0.2 – 2.1  0.2 (0.2 - 0.3) 2.1 (2 - 2.1) 
Neutrophil % 967 52 (43.5 - 59.4) 
 
27.2 – 71.9 27.2 (25.4 - 29.9) 71.9 (69.6 - 73.1) 
Lymphocyte % 967 35.4 (29.4 - 42.1) 
 
19.8 – 57.4 19.8(18.8 - 20.9) 57.4 (56 - 58.1) 
Mixed cells % 967 11.3 (8.9 - 15.2) 
 
5.2 – 26.4 5.2 (4.5 - 5.6) 26.4 (25.2 - 28 
PLT (×109/L) 967 239 (186 - 293) 
 
90 – 399 90 (84 - 94) 399 (381 - 417) 
RBC (×1012/L) Male 534 5.1 (4.8 - 5.5) 4.0 – 6.0  4 (3.9 - 4.2) 6 (6 - 6.2) 
Female 433 4.5 (4.2 - 4.8) 3.5 – 5.6 
 
3.5 (3.4 - 3.6) 5.6 (5.4 - 5.9) 
Hgb (g/dl) Male 534 15.3 (14.2 - 16.5) 12 – 18.9 12 (11.6 - 12.2) 18.9 (18.5 - 19.3) 
Female 433 13.1 (12.1 - 14.3) 10.7 – 17.5 
 
 10.7 (10.5 - 11) 17.5 (17 - 18.3) 
PCV (%) Male 534 46.2 (43.6 - 49.2) 35.7 – 55.3 35.7 (34.8 - 36.9) 55.3 (54.2 - 56) 
Female 433 39.9 (37.6 - 43.5) 32.2 – 50.1 
 
32.2 (31 - 33) 50.1 (48.5 - 52.4) 
MCV (fl) 967 90.1 (87 - 93) 81 – 100 
 
81 (80.4 - 82) 99.7 (98.7 - 100.7) 
MCH (pg) 967 30 (28.1 - 31.7) 25.3 – 34.6 
 
25.3 (25.1 - 25.7) 34.5 (34.3 - 35.2) 
MCHC (%) 967 33.9 (30.5 - 35.1) 28.8 – 36.9 
 
28.8 (28.5 - 29) 36.9 (36.6 - 37.1) 
RDW (%) 967 13.2 (12.7 - 13.8) 11.6 – 15.4 
 
11.6 (11.4 - 11.8) 15.4 (15.2 - 15.7) 
MPV (fl) 967 10 (9.3 - 10.6) 8 – 12.3 
 
8 (7.9 - 8.2) 12.3 (12 - 12.4) 
 
CD4 (×109/L) 
Male 446 715 (592 - 874) 400 - 1406 400 (370 - 431) 1406 (1250 - 1477) 
Female 338 830 (677 - 1017) 466 - 1523 465 (388 - 494) 1523 (1412 - 1621) 
CD4 % Male 446 36.3 (31.8 - 40.7) 18 - 49.1 18 (15.7 - 20.6) 49.1 (47.9 - 49.9) 
Female 338 40.3 (34.6 - 44.7) 21.3 - 52.9 21.3 (15.9 - 25.6) 52.9 (51.1 - 55.4) 
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Table 3: Comparison of hematological RIs of the current study with previous studies in Africa, USA and test books  
 
Parameters 
  
Current 
Study 
Gondar, 
Ethiopia 
(14) 
Gojjam, 
Ethiopia 
(15) 
Kericho, 
Kenya 
(31) 
Eastern & 
Southern 
Africa (6) 
Ghana 
(29) 
Southern 
Tanzania 
(36) 
Uganda (4) Togo (35) USA (30) Rodak's 
Hematolog
y (34) 
WBC (×109/L) 3 - 11.2 3.2 - 8.8 3.5 - 11.5 2.8 - 8.2 3.1 - 9.1 3.4 - 9.2 3 - 7.9 2.8 - 8.2 1.9 - 10.1 4.5 - 11 3.6 - 10.6 
Neutrophil (×109/L) 1.1 - 6.7 1.6 - 5.1 NA 0.9 - 4.7 1.0 - 5.3 1.5 - 5.6 1.1 - 4.7 0.9 - 3.9 0.5 - 5.4 NA 1.7 - 7.5 
Lymphocyte 
(×109/L) 
1.1 - 4.5 1 - 3.5 NA 1.1 - 3.5 1.2 - 3.5 1.2 - 4.4 1.1 - 3 1.2 - 3.7 1.1 - 4.3 NA 1 - 3.2 
Mixed cells (×109/L) 0.2 - 2.1  0.2 - 1 NA NA NA NA 0.3 - 1.1 NA NA NA NA 
Neutrophil % 27.2 - 71.9 36 - 69 34.3 - 72.1 20–60 25 - 66 32 - 68.1 32 - 69.1 22.2 - 59.3 NA 40 - 70 50 - 70 
Lymphocyte % 19.8 - 57.4 22 - 55 17.9 - 53.4 20–60 23 - 59 25.2 - 57.7 20.8 - 56.7 26.7 - 61.2 NA 22 - 44 18 - 42 
Mixed cells % 5.2 - 26.4 6 -13 6 -23 NA NA NA 5.6 - 19.8 NA NA   NA 
PLT (×109/L) 90 - 399 128 - 432 113.9 - 372 120 - 411 126 -438 89 - 380 150 - 395 109 - 384 120 - 443 150 - 350 150 - 450 
RBC (×1012/L) M 4.0-6.0 3.53 - 6.93 3.9 - 6.2 4 - 6.4 4.4 - 6.3 3.79–5.96 4.41 - 6.27 3.8 - 6.1  3.3 - 6.4 4.5 - 5.9 4.2 - 6 
F 3.5 - 5.6 3.45 - 6.25 3.9 - 5.8 3.8 - 5.6 3.7 - 5.6 3.09–5.30 3.84 - 5.59 3.3 - 5.3 3.1 - 6 4 - 5.2 3.8 -5.2 
Hgb (g/dl) M 12- 18.9 11.5 - 18 13.6 - 19.8 12.2 - 17.7 8.3 - 11.3 11.3–16.4 13.7 - 17.7 11.6 - 17.1 10 - 18.4 13.5 - 17.5 13.5 - 18 
F 10.7 - 17.5 10.9 - 16.9 12 - 18 9.5 - 15.8 5.9 - 10 88–144 11.1 - 15.7 9.8 - 16.2 10.3 - 17.1 12 - 16 12-15 
PCV (%) M 35.7 - 55.3 36.2 - 58.6 45 - 59 35 - 50.8 40 - 50 33.2–50.5 40.2 - 53.7 33.8 - 49.5 28 - 54 41 - 53 40 - 54 
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F 32.2 - 50.1 32.1 - 56.6 39 - 55 9.4–45.4 30 - 50 26.4–45.0 36.2 - 46.8 28.3 - 46.8 28 - 47 36 - 46 35 - 49 
MCV (fl) 81 - 100 85 - 100 89.5 - 107.5 68.8 - 97.2 68 - 98 72 - 97 77.6 - 98.1 71 - 97 80 - 99 80 - 100 80 - 100 
MCH (pg) 25.3- 34.6 NA 28 - 34 22.4 - 33.5 NA 22.6 - 33.5 23.6 - 33.1 23.5 - 33.7 25 - 37 26 - 34 26 - 34 
MCHC (%) 28.8 - 36.9  NA 30 - 33.2 32.2–35.3 NA 30.5 - 36.2 30.6 – 34.9 32.5 - 35.3 29 - 41 31 - 37 32 - 36 
RDW (%) 11.6 - 15.4 12-18 NA NA NA 12.6 - 23 NA 11 - 16.8 NA 11.5–14.5 11.5 - 14.5 
MPV (fl) 8 - 12.3  NA  NA NA NA NA NA NA NA NA 7 - 12 
 
N.B: NA; not applicable (there is no value) 
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Table 4: Comparison of CD4 and CD4% RIs of the current study with previous studies in Ethiopia, other African countries and Turkey  
 
 
Parameters  
  
Current 
Study 
Gojjam, 
Ethiopia 
(15) 
Addis 
Ababa, 
Ethiopia 
(16) 
Western 
Kenya (7) 
Central 
African 
Republic 
(20)  
Northern 
Tanzania 
(21) 
Uganda (19)  Gauteng, 
South Africa 
(45) 
Turkey (46) 
CD4 (×109/L) M 400 – 1430  414 – 1474  306 - 1,249 462–1306 391–1,145 362–1,376 503 - 1807 291.2–
1278.9 
438 - 1,890 
F 466 – 1523  436 – 1695 456 –1,368 440–1602 386–1,355 454–1,485 561 - 2051 288.5–
1406.8 
394 - 2,234 
CD4% 
  
M 18 – 49.1  NA NA 32–55 23–54 16.5–45.3 27.7 - 56.7 NA 29.91 - 60.12 
F 21.3 – 52.9 NA NA 29–54 29–55 22.5–48.3 31.6 - 58.0 NA 29.74 - 61.41 
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